Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Pennsylvania

Phase 2 colorectal cancer trials in Pennsylvania

10 Phase 2 colorectal cancer studies are recruiting participants at sites in 10 cities across Pennsylvania as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Pennsylvania city with a recruiting study

Pittsburgh (5), Philadelphia (3), Hershey (2), Allentown (1), Chadds Ford (1), Danville (1), Lancaster (1), Lewisburg (1), Wilkes-Barre (1), Wynnewood (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Pennsylvania

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Allentown
    Registry record
    NCT04165772 · updated
  2. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Chadds Ford · Danville · Hershey · and 3 more U.S. locations
    Registry record
    NCT05673148 · updated
  3. A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Criterium, Inc.
    Recruiting in
    Lancaster · Philadelphia · Pittsburgh
    Registry record
    NCT06992258 · updated
  4. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Philadelphia
    Registry record
    NCT07023289 · updated
  5. A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    NSABP Foundation Inc
    Recruiting in
    Pittsburgh
    Registry record
    NCT07058012 · updated
  6. A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Kahr Bio Australia Pty Ltd
    Recruiting in
    Pittsburgh
    Registry record
    NCT07235293 · updated
  7. A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ono Pharmaceutical Co., Ltd.
    Recruiting in
    Philadelphia
    Registry record
    NCT06948448 · updated
  8. A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    SCRI Development Innovations, LLC
    Recruiting in
    Wynnewood
    Registry record
    NCT07011576 · updated
  9. Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Diwakar Davar
    Recruiting in
    Pittsburgh
    Registry record
    NCT07223424 · updated
  10. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Apollomics Inc.
    Recruiting in
    Hershey
    Registry record
    NCT03175224 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Pennsylvania on ClinicalTrials.gov.

Ask about studies in Pennsylvania

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call